Cardio Diagnostics Holdings, Inc. (CDIOW) Stock Price & Analysis
Cardio Diagnostics Holdings, Inc. (CDIOW) rose 21.67% to USD 0.01 as of July 26, 2026 at 07:51 UTC, according to Nexqual real-time market data.
CDIOW last closed at USD 0.01; the session ranged USD 0.01–0.02 on volume of 752 shares. Market capitalization is —, with a 52-week range of USD 0.01–0.02 (NCM). Source: Nexqual, July 26, 2026 at 07:51 UTC.
Key Statistics (as of July 26, 2026 at 07:51 UTC)
| Price | USD 0.01 |
|---|---|
| Change | ▲ 21.67% (up) |
| Previous Close | USD 0.01 |
| Open | USD 0.02 |
| Day Range | USD 0.01 – 0.02 |
| 52-Week Range | USD 0.01 – 0.02 |
| Volume | 752 shares |
| Market Cap | — |
| Exchange | NCM |
Analyst Ratings (CDIOW)
Wall Street analysts rate CDIOW "None", per Nexqual as of July 26, 2026 at 07:51 UTC.
| Consensus Rating | None |
|---|
Earnings (CDIOW)
Source: Nexqual, July 26, 2026 at 07:51 UTC.
Financials & Fundamentals (CDIOW)
| Total Revenue | $16,565 |
|---|---|
| Revenue Growth (YoY) | +185.10% |
| Gross Margin | +100.00% |
| Operating Margin | -66598.40% |
| Profit Margin | +0.00% |
| ROE | -65.59% |
| Debt / Equity | 5.99 |
| Current Ratio | 15.76 |
| Total Cash | $7.08M |
| Total Debt | $533,002 |
| Free Cash Flow | $-3.93M |
Source: Nexqual, July 26, 2026 at 07:51 UTC.
Financial Health Score (CDIOW)
Nexqual rates Cardio Diagnostics Holdings, Inc.'s overall financial health "Mixed" across five dimensions, as of July 26, 2026 at 07:51 UTC.
| Growth | Strong — Revenue +104% YoY (annual) |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Strong — $7M cash, no debt |
| Cash Flow | Weak — FCF negative: -$4M, burning cash |
| Efficiency | Critical — ROE -66%, ROA -38.0% |
Ownership (CDIOW)
| Float | 2.83M |
|---|
Source: Nexqual, July 26, 2026 at 07:51 UTC.
Leadership (CDIOW)
Cardio Diagnostics Holdings, Inc. is led by Meeshanthini V. Dogan (age 36), Co-Founder, CEO & Director, per Nexqual as of July 26, 2026 at 07:51 UTC.
| Co-Founder, CEO & Director | Meeshanthini V. Dogan (age 36) |
|---|---|
| CFO & Principal Accounting Officer | Elisa Michael Luqman Esq. (age 61) |
| Chief Technology Officer | Timur Dogan (age 36) |
| Co-Founder, Chief Medical Officer & Director | Robert A. Philibert (age 63) |
Major Backers & Investors (CDIOW)
Notable institutional backers of Cardio Diagnostics Holdings, Inc. include Saba Capital Management, L.P., Clear Street Group Inc., Context Capital Management, LLC, according to Nexqual as of July 26, 2026 at 07:51 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Saba Capital Management, L.P. | 6.76% |
| Clear Street Group Inc. | 2.53% |
| Context Capital Management, LLC | 2.51% |
| Shaw D.E. & Co., Inc. | 2.3% |
| Boothbay Fund Management, LLC | 1.86% |
| Virtu Financial LLC | 0.95% |
| UBS Group AG | 0.17% |
Source: Nexqual, July 26, 2026 at 07:51 UTC.
From Cardio Diagnostics Holdings, Inc.'s Latest SEC 10-K Filing (filed 2026-03-13)
Key Strengths & Strategy (as disclosed to the SEC)
- Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease.
- The company offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment clinical blood test targeting CHD events, including heart attacks; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform that offers new epigenetic and genetic insights to clinicians prescribing to help improve chronic care management.
- It also provides CardioInnovate360, a research-use-only solution to support the discovery, development and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases; and HeartRisk, a SaaS cardiovascular disease risk intelligence platform.
- It serves telemedicine providers; provider organizations, such as concierge practices, longevity clinics, and risk-bearing provider organizations; and employer organizations.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CDIO | Cardio Diagnostics Holdings Inc | USD 1.55 | ▼ 7.74% |
| ICUCW | SeaStar Medical Holding Corporation | USD 0.02 | ▲ 28.8% |
| REVBW | Revelation Biosciences, Inc. | USD 0.01 | ▲ 1.01% |
| HUBCW | Hub Cyber Security Ltd. Warrant | USD 0.01 | ▼ 5.41% |
| BIAFW | bioAffinity Technologies, Inc. | USD 0.09 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 26, 2026 at 07:51 UTC. This page is informational and not investment advice.